4Blox, Inc. is a software company dedicated to improving Internet Small Computer System Interface (iSCSI) Storage Area Network (SAN) performance. The most important hardware resource for efficiently handling increased load in iSCSI processing is CPU capacity. The core product from 4Blox™ is a family of software components used to expand CPU processing capacity in iSCSI SAN.
Axon Technologies Corporation is a technology development and licensing company. It was founded in 1996 to develop and commercialize its revolutionary and proprietary memory and switching technology, the Programmable Metallization Cell (PMC). PMC is the cornerstone of integrated ionics, a new and exciting field being pioneered by Axon and one that has generated applications from solid-state data storage to optoelectronics.
Founded in 2005, BioSense International, Inc. designs and manufactures highly sophisticated electro optical instruments and reagents used for the rapid detection and characterization of pathogens in water.
Cantimer, Inc., has developed and is commercializing proprietary products that allow continuous and non-invasive salivary commonality measurements to service the largely untapped market of human hydration optimization. The company is developing a line of hydration sensors composed of a base module and replaceable polymer testing tips. The hydration sensor is based on a patented technology exclusively licensed from Northern Arizona University and expanded by Bay Materials, LLC. The technology, as applied in this context, will measure saliva commonality to determine the state of human hydration. The initial market will focus on healthcare, including geriatrics, pediatrics, anesthesiology, and the US Military.
constructNet International Inc. (cNI) is a joint venture spinout company anchored by Arizona State University and Technologico de Monterrey, Mexico's largest private university. cNI is a single source for individuals, companies and organizations in the construction industry for best-in-class solutions to their education and training needs. Ranging from construction management for professional development and continuing education, to building skills and competencies for technicians and crafts people, cNI offers a broad menu of online and classroom-based courses and programs.
Crawdad Technologies, LLC provides software and services to analysts and research professionals who need to transform unstructured text into insight. Crawdad’s content analysis software is based on Centering Resonance Analysis which uses natural language processing to create a network model of text to analyze texts, documents and other human communication in an effort to help its customers understand, control and improve their processes and systems. Crawdad’s Listening Post™ provides web services to monitor today’s dynamic, emergent, consumer-driven media – listens to blogs, social networks, web sites, discussion boards, news media, and periodicals -- discovering who is talking, what they are saying, and what to pay attention to.
Fluidic Fuel Cell, LLC (formerly named TruSyn) is an ASU spin-out created to develop nanoscale materials for hydrogen storage and fuel cell production. The company was created to commercialize technology developed by Dr. Cody Friesen, Professor in the Dept. of Chemical and Materials Engineering. The three main technological roadblocks that must be overcome for any potential hydrogen economy to come about are hydrogen production, hydrogen storage and hydrogen use. Fluidic Fuel Cell is addressing each of these issues with government funding as well as private venture funding that was successfully raised in 2006.
Intrinsic Bioprobes Inc. (IBI) is a privately held biotechnology company that develops innovative technologies for rapid and sensitive proteomics and biomarker analysis. IBI applies its innovations through protein analysis services and research partnerships. Organizations working with IBI can accelerate their drug development cycles, increase the efficacy of therapies in development, and reduce bottom line expenses. The company's proprietary technologies consist of Bioreactive Mass Spectrometer Probes (BRP™), simple devices for rapid, sensitive and accurate protein characterization, and Mass Spectrometric Immunoassay (MSIA™), a high-performance approach for the selective isolation of proteins from complex biological matrices. These root technologies are incorporated into the MASSAY™ Integrated System, a high throughput mass spectrometry approach geared for proteome characterization.
NeuroVista Corporation is an early-stage medical device company pioneering new technologies that will revolutionize the management and treatment of epilepsy.
PetroAlgae, LLC is utilizing natural strains of micro-algae and bred selectively over many generations to produce rapid growth and extremely high oil yield. The modular algae cultivation bioreactor system can be built and operated on a massive commercial scale, creating the opportunity to produce a cost effective alternative to traditional oil supplies. The patented algae strains are not only a great natural oil source, but also capable of being used to absorb carbon dioxide from the atmosphere and contaminants from waste water.
USuggest, LLC has developed patent-pending technology that allows online shoppers to get commissions for the discoveries they make while shopping online. Using a software tool called InstantValue, shoppers highlight any deal on the Web, tag it, and submit it to USuggest which then instantly lists the suggestion and tracks responses from other shoppers. Deals that users post to the Web site are ranked according to click-through rates and sales conversions, and the highest ranked suggestions earn commission rewards for the individuals who posted the deal.
AcquisitionsOrthoLogic is a biotechnology company committed to developing a pipeline of novel therapeutic peptides and other molecules aimed at helping patients with under-served medical conditions. In February 2006, they acquired AzERx, changing the name of the product to AZX100 is a novel synthetic pre-clinical 24-amino acid peptide, one of a new class of compounds in the field of smooth muscle relaxation and fibrosis. AZX100 is currently being evaluated for commercially significant medical applications such as the treatment of pulmonary disease, the prevention of hypertrophic and keloid scarring and intimal hyperplasia. OrthoLogic has an exclusive worldwide license to AZX100.
In Jan 2008, Caris MPI was officially formed from the combination between the Molecular Profiling Institute and Caris Diagnostics (Caris Dx), the leading provider of pathology services to GI physicians. In 2004, Molecular Profiling Institute had acquired NanoBiomics,a technology that has the potential to detect the early stages of disease and may also further the development of personalized medicine, allowing doctors to administer the right drug for the right person. Together with other mergers and acquisitions, Caris MPI is a new paradigm in reference lab testing that offers comprehensive information about a patient's disease in a personalized format for their physicians and for clinical research sponsors. Caris MPI introduces discoveries made in the research lab to clinical patient care. Caris MPI is currently offering tests to help oncologists to better understand and treat cancer patients with personalized treatment plans based on the molecular characteristics of their tumors. ]
Agilent's electronic measurement business provides standard and customized electronic measurement instruments and systems, monitoring, management and optimization tools for communications networks and services, software design tools and related services that are used in the design, development, manufacture, installation, deployment and operation of electronics equipment and communications networks and services. In November 2005, Agilent, Inc. acquire Molecular Imaging, a premier developer and supplier of Atomic Force Microscope and Scanning Probe Microscope systems, accessories and software for high resolution AFM and STM imaging in fluids, ambient or air under controlled temperature and environmental conditions. Their products are designed for nanotechnology research applications in life science, biotechnology, electrochemistry and material and polymer science.
In June 2006, W. L. Gore & Associates, Inc. acquired Neural Intervention Technologies, Inc. (NIT), a medical device company developing a novel liquid embolic material for the treatment of blood vessel defects. NIT was founded in 2003 based on the ALGEL™, an alginate based embolic material designed to fill blood vessel defects thereby displacing blood pressure effects and preventing vessel rupture. The material is delivered by microcatheters using a controlled delivery system for the treatment of vascular diseases such as cerebral Arteriovenous Malformations (AVMs) and aneurysms. Gore's acquisition of NIT provides a unique opportunity to provide superior treatments for patients with blood vessel defects or suffering from hemorrhagic stroke and builds on Gore’s larger initiative of offering a complete portfolio of products which address stroke.
